VLST Corp. Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer

Published: Jul 02, 2008

SEATTLE--(BUSINESS WIRE)--VLST Corporation, a Seattle-based biotechnology company focused on the development of therapeutics for autoimmune and inflammatory disorders, today announced that Paul J. Carter, Ph.D., a 20-year biotechnology research veteran, will join the Company as chief scientific officer and senior vice president of research and development.

Back to news